ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hübner, R. H.
Right arrow Articles by Bewig, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hübner, R. H.
Right arrow Articles by Bewig, B.
Eur Respir J 2005; 25:494-501
Copyright ©ERS Journals Ltd 2005

Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation

R. H. Hübner1, S. Meffert1, U. Mundt1, H. Böttcher2, S. Freitag3, N. E. El Mokhtari1, T. Pufe4, S. Hirt5, U. R. Fölsch1 and B. Bewig1

1 Dept of Internal Medicine, and 2 Dept of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Campus Kiel, 3 Institute for Medical Informatics and Statistics, and 4 Institute of Anatomy, Christian-Albrechts-University Kiel, and 5 Dept of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Germany

CORRESPONDENCE: R. H. Hübner, Dept of Internal Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Schittenhelmstr.12, 24105 Kiel, Germany. Fax: 49 4315971302. E-mail: rhuebner@1med.uni-kiel.de

Keywords: Bronchiolitis obliterans syndrome, bronchoalveloar lavage, lung transplantation, matrix metalloproteinase, polymorphonuclear cells, tissue inhibitors of matrix metalloproteinases

Received: August 3, 2004
Accepted November 24, 2004

Bronchiolitis obliterans syndrome (BOS) is a severe complication after lung transplantation (LTX).

In a retrospective cohort study 12 stable healthy recipients (non-BOS) and eight patients with BOS were enrolled after LTX and matrix metalloproteinases (MMP)-9, TIMP-1 and cell characteristics in bronchoalveolar lavage (BAL) samples (n = 145) were analysed. BALs from patients with BOS were further divided according to whether they were obtained before (pre-BOS) or after manifestation of BOS (BOS group).

The MMP-9/TIMP-1 ratio was significantly increased in the BOS group compared with non-BOS or pre-BOS; furthermore, the ratio was negatively correlated with forced expiratory volume in one second. In zymography, the active form of MMP-9 was detected predominantly in the BOS group. In addition, zymography showed the banding pattern of neutrophil-derived MMP-9, indicating that polymorphonuclear neutrophils (PMNs) were the main source of MMP-9. According to that, MMP-9 was significantly correlated with the number of PMN. In immunocytochemistry, MMP-9 was also associated predominantly with PMN.

This is the first study to evaluate the expression of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 over time during manifestation of a fibroproliferative lung disease in patients. It demonstrates development of bronchiolitis obliterans syndrome after lung transplantation is associated with an imbalance of matrix metalloproteinases-9/tissue inhibitors of metalloproteinase-1 ratio.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
P. Chen, J. K. McGuire, R. C. Hackman, K.-H. Kim, R. A. Black, K. Poindexter, W. Yan, P. Liu, A. J. Chen, W. C. Parks, et al.
Tissue Inhibitor of Metalloproteinase-1 Moderates Airway Re-Epithelialization by Regulating Matrilysin Activity
Am. J. Pathol., May 1, 2008; 172(5): 1256 - 1270.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
K. J. Greenlee, Z. Werb, and F. Kheradmand
Matrix Metalloproteinases in Lung: Multiple, Multifarious, and Multifaceted
Physiol Rev, January 1, 2007; 87(1): 69 - 98.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Bharat, R. C. Fields, E. P. Trulock, G. A. Patterson, and T. Mohanakumar
Induction of IL-10 Suppressors in Lung Transplant Patients by CD4+25+ Regulatory T Cells through CTLA-4 Signaling
J. Immunol., October 15, 2006; 177(8): 5631 - 5638.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. M. Verleden, B. M. Vanaudenaerde, L. J. Dupont, and D. E. Van Raemdonck
Azithromycin Reduces Airway Neutrophilia and Interleukin-8 in Patients with Bronchiolitis Obliterans Syndrome
Am. J. Respir. Crit. Care Med., September 1, 2006; 174(5): 566 - 570.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
L. P. Nicod
Mechanisms of airway obliteration after lung transplantation.
Proceedings of the ATS, July 1, 2006; 3(5): 444 - 449.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
P. Chen, A. S. Farivar, M. S. Mulligan, and D. K. Madtes
Tissue Inhibitor of Metalloproteinase-1 Deficiency Abrogates Obliterative Airway Disease after Heterotopic Tracheal Transplantation
Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 464 - 472.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
P T G Elkington and J S Friedland
Matrix metalloproteinases in destructive pulmonary pathology
Thorax, March 1, 2006; 61(3): 259 - 266.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the European Respiratory Society.